# Title
Detection O
of O
inborn B-Disease
errors I-Disease
of I-Disease
fatty B-Chemical
acid I-Chemical
oxidation I-Disease
from O
acylcarnitine B-Chemical
analysis O
of O
plasma O
and O
blood O
spots O
with O
the O
radioisotopic O
exchange-high-performance O
liquid O
chromatographic O
method. O

# Abstract
Sixty-one O
plasma O
samples O
from O
patients B-Species
with O
inborn B-Disease
errors I-Disease
of I-Disease
fatty B-Chemical
acid I-Chemical
oxidation I-Disease
and O
from O
control O
subjects O
were O
analyzed O
in O
a O
blinded O
fashion O
for O
acylcarnitines B-Chemical
by O
the O
radioisotopic O
exchange-high-performance O
liquid O
chromatographic O
method. O
All O
samples O
from O
patients B-Species
with O
medium-chain B-Disease
acyl-coenzyme I-Disease
A I-Disease
dehydrogenase I-Disease
(MCAD) B-Disease
deficiency I-Disease
(n O
= O
30), O
some O
of O
which O
had O
been O
stored O
in O
a O
frozen O
state O
for O
several O
years, O
showed O
a O
prominent O
octanoylcarnitine B-Chemical
peak. O
In O
all O
blood O
spots O
from O
11 O
patients B-Species
with O
MCAD B-Disease
deficiency, I-Disease
octanoylcarnitine B-Chemical
was O
also O
detected. O
Control O
plasma O
specimens O
and O
blood O
spots O
contained O
small O
amounts O
of O
octanoylcarnitine; B-Chemical
however, O
the O
octanoylcarnitine B-Chemical
acetylcarnitine B-Chemical
ratio O
differentiated O
patients B-Species
with O
MCAD B-Disease
deficiency. I-Disease
Longer-chain O
acylcarnitines B-Chemical
were O
found O
in O
plasma O
of O
all O
three O
patients B-Species
with O
defects O
in O
long-chain B-Chemical
fatty B-Chemical
acid I-Chemical
oxidation. O
Plasma O
and O
blood O
spots O
from O
a O
patient B-Species
with O
multiple B-Disease
acyl-coenzyme I-Disease
A I-Disease
dehydrogenase I-Disease
deficiency I-Disease
contained O
C4-acylcarnitine, B-Chemical
hexanoylcarnitine, B-Chemical
octanoylcarnitine, B-Chemical
and O
decanoylcarnitine. B-Chemical
The O
results O
suggest O
that O
the O
method O
may O
be O
highly O
sensitive O
in O
detecting O
MCAD B-Disease
deficiency I-Disease
and O
other O
defects O
in O
fatty B-Chemical
acid I-Chemical
oxidation O
from O
plasma O
or O
blood O
spots. O